CSF3 and Decreased total neutrophil count: The present observational study was designed to provide updated information about patterns of use of G-CSFs in the clinical practice of Spanish oncology services and to compare neutropenia-related outcomes in patients treated with a daily G-CSF compared with patients treated with a non-daily G-CSF (pegfilgrastim), after adjusting by potential confounders.